Safety and efficacy of extended versus standard interval dosing of natalizumab in multiple sclerosis patients: a systematic review and meta-analysis
Article in Acta Neurologica Belgica (March 2024)
The most recent citing publications are shown below. View all 20 publications that cite this research output on Dimensions.
Article in Acta Neurologica Belgica (March 2024)
Article in Neurotherapeutics (February 2024)
Article in Drug Safety (February 2024)